Pulmonary rehabilitation as evaluated by clinical trials: An overview

Reviews on Recent Clinical Trials

Volumn 5, Issue 2, 2010, Pages 76-84

  Riario Sforza, Gian Galeazzo ^a   Yacoub, Mona Rita ^b   Incorvaia, Cristoforo ^a  

^a ICP Hospital   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Chronic obstructive lung disease; Dyspnea; Physical capacity; Pulmonary rehabilitation; Quality of life

Indexed keywords

PAROXETINE; SERTRALINE;

ANXIETY DISORDER; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE THERAPY; DEPRESSION; DYSPNEA; EVIDENCE BASED PRACTICE; EXERCISE TOLERANCE; FUNCTIONAL STATUS; HUMAN; LONG TERM CARE; MORTALITY; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SELECTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; PULMONARY REHABILITATION; QUALITY OF LIFE; SELF CONCEPT; TREATMENT OUTCOME;

AMBULATORY CARE; EXERCISE THERAPY; HUMANS; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

EID: 77952826207     PISSN: 15748871     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488710791233617     Document Type: Article

References (109)

1. Rabe KF, Hurd S, Anzueto A, et al, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease [GOLD] Executive summary. Am J Respir Crit Care Med 2007; 532-55.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020. Lancet 1997; 349: 1498-504.
3. Nici L, Donner C, Wouters E, et al. American Thoracic Society/ European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-413.
4. Belman MJ, Kendregan BA. Exercise training fails to increase skeletal muscle enzymes in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1981; 123: 256-61.
5. Belman MJ. Exercise in chronic obstructive pulmonary disease. Clin Chest Med 1986; 7: 585-97.
6. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143: 9-18.
7. Maltais F, LeBlanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 442-7.
8. Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R. Exercise training decreases ventilatory requirements and exercise induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005; 128: 2025-34.
9. Allaire J, Maltais F, Doyon JF, et al. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 2004; 59: 673-8.
10. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 629-34.
11. Saey D, Debigare R, LeBlanc P, et al. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 425-30.
12. O'Shea SD, Taylor NF, Paratz J. Peripheral muscle strength training in COPD: a systematic review. Chest 2004; 126: 903-14.
13. Foster S, Thomas HM III. Pulmonary rehabilitation in lung disease other than chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 141: 601-4.
14. Petty TL, Nett LM, Finigan MM, Brink GA, Corsello PR. A comprehensive care program for chronic airway obstruction: methods and preliminary evaluation of symptomatic and functional improvement. Ann Intern Med 1969; 70: 1109-20.
15. Maltais F, Bourbeau J, Shapiro S, et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2008; 149: 869-78.
16. Cambach W, Chadwick-Straver RVM, Wagenaar RC, van Keimpema ARJ, Kemper HCG. The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. Eur Respir J 1997; 10: 104-13.
17. Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt GH. Randomised controlled trial of respiratory rehabilitation. Lancet 1994; 344: 1394-7.
18. Rodriguez JC, Ilowite JS. Pulmonary rehabilitation in the elderly patient. Clin Chest Med 1993; 14: 429-36.
19. Ambrosino N, Foglio K. Selection criteria for pulmonary rehabilitation. Respir Med 1996; 90: 317-22.
20. Hamdorf PA, Withers RT, Penhall RK, Plummer J. A follow-up study on the effects of training on the fitness and habitual activity patterns of 60-to 70-year old women. Arch Phys Med Rehabil 1993; 74: 473-7.
21. Fiatarone MA, O'Neill EF, Doyle RN et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994; 330:1769-75.
22. Stulbarg MS, Carrieri-Kohlman V, Demir-Deviren S, et al. Exercise training improves outcomes of a dyspnea self-management program. J Cardiopulm Rehabil 2002; 22: 109-21.
23. Ferreira G, Feuerman M, Spiegler P. Results of an 8-week, Outpatient pulmonary rehabilitation Program on patients with and without chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2006; 26: 54-60.
24. Lacasse Y, Guyatt GH, Goldstein RS. The components of a respiratory rehabilitation program: a systematic overview. Chest 1997; 111: 1077-88.
25. British Thoracic Society Standard of Care Subcommittee on Pulmonary Rehabilition. Pulmonary rehabilitation. Thorax 2001; 56: 827-34.
26. Maltais F, LeBlanc P, Jobin J. Intensity of training and physiological adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 555-61.
27. American College of Sports Medicine Position Stand. Exercise and physical activity for older adults. Med Sci Sports Exerc 1998; 30: 992-1008.
28. Nici L, Donner C, Wouters E, et al. American Thoracic Society/ European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med 2006; 173:1390-413.
29. O'Shea SD, Taylor NF, Paratz J. Peripheral muscle strength training in COPD: a systematic review. Chest 2004; 126: 903-14.
30. Gigliotti F, Coli C, Bianchi R, et al. Exercise training improves exertional dyspnea in patients with COPD: evidence of the role of mechanical factors. Chest 2003; 123: 1794-802.
31. Weiner P, Magadle R, Beckerman M, Weiner M, Berar-Yanay N. Comparison of specific expiratory, inspiratory, and combined muscle training programs in COPD. Chest 2003; 124: 1357-64.
32. British Thoracic Society Standards of Care. Subcommittee on Pulmonary Rehabilitation. Pulmonary rehabilitation. Thorax 2001; 56: 827-34.
33. Horowitz MB, Littenberg B, Mahler DA. Dyspnea ratings for prescribing exercise intensity in patients with COPD. Chest 1996; 109: 1169-75.
34. Vallet G, Ahmaidi S, Serres I, et al. Comparison of two training programmes in chronic airway limitation patients: standardized versus individualized protocols. Eur Respir J 1997; 10: 114-22.
35. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007; 131: 4S-42S.
36. Costi S, Crisafulli E, Degli AF, Benedenti C, Fabbri LM, Clini EM. Effects of unsupported upper extremity exercise training in patients with COPD: a randomized clinical trial. Chest 2009; 136(2): 387-95.
37. Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005; 127: 809-17.
38. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003; 168:1034-42.
39. Valli G, Paletti P, Savi D, Marzolini D, Palange P. Clinical use of Heliox in asthma and COPD. Monaldi Arch Chest Dis 2007; 67:159-64.
40. Hawkins P, Johnson LC, Nikoletou D, et al. Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease. Thorax 2002; 57: 853-9.
41. Casaburi R, Bhasin S, Cosentino L, et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 870-8.
42. Brooks D, Sottana R, Bell B, et al. Characterization of pulmonary rehabilitation programs in Canada in 2005. Can Respir J 2007; 14: 87-92.
43. Bickford LS, Hodgkin JE, McInturff SL. National pulmonary rehabilitation survey: update. J Cardiopulm Rehabil 1995; 15: 406-11.
44. Yohannes AM, Connolly MJ. Pulmonary rehabilitation programmes in the UK: a national representative survey. Clin Rehabil 2004;18: 444-9.
45. Effing T, Monninkhof EM, van der Valk PD, et al. Selfmanagement education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009; CD002990.
46. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003; 48: 1204-13.
47. Bourbeau J, Julien M, Maltais F, et al., Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Sante du Quebec. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease. Arch Intern Med 2003;163: 585-91.
48. Bourbeau J, Nault D, Dang-Tan T. Self-management and behavior modification in COPD. Patient Educ Couns 2004; 53: 271-7.
49. Troosters T, Gosselink R, De Paepe K. Pulmonary rehabilitation improves survival in COPD patients with a recent severe acute exacerbation. Am J Respir Crit Care Med 2002; 165: 16.
50. Man WD, Polkey MI, Donaldson M, Gray BJ, Moxham J. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004; 329:1209.
51. Puhan MA, Scharplatz M, Troosters T, Steurer J. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality: a systematic review. Respir Res 2005; 6: 54-9.
52. Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005; 127:1205-11.
53. Yohannes AM, Roomi J, Waters K, Connolly MJ. Quality of life in elderly patients with COPD: measurement and predictive factors. Respir Med 1998; 92(10): 1231-6.
54. Meek PM, Lareau SC, Anderson D. Memory for symptoms in COPD patients: how accurate are their reports. Eur Respir J 2001; 18(3): 474-81.
55. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-7.
56. Stage KB, Middleboe T, Pisinger C. Depression and chronic obstructive pulmonary disease [COPD]. Impact on survival. Acta Psychiatr Scand 2005; 111: 320-3.
57. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167: 60-7.
58. Smoller JW, Pollack MH, Systrom D, Kradin RL. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics 1998; 39: 24-9.
59. Lacasse Y, Beaudoin L, Rousseau L, Maltais F. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis 2004; 61:140-7.
60. Lisansky D, Hendel-Clough D. A cognitive-behavioral self help educational program for patients with COPD: a pilot study. Psychother Psychosom 1996; 65: 97-101.
61. Eiser N, West C, Evans S, Jeffers A, Quirk F. Effects of psychotherapy in moderately severe COPD: a pilot study. Eur Respir J 1997; 10: 1581-4.
62. Kunik ME, Braun U, Stanley MA, et al. One session cognitive behavioral therapy for elderly patients with chronic pulmonary disease. Psychol Med 2001; 31: 717-23.
63. De Godoy D, de Godoy R. A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2003; 84: 1154-7.
64. Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung 2009; 38: 34-47.
65. Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J Psychosom Res 2007; 63: 551-65.
66. Coventry PA. Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Curr Opin Pulm Med 2009; 15(2): 143-9.
67. World Health Organization. Overweight and obesity: a new nutrition emergency? Monitoring the rapidly emerging public health problem of overweight and obesity: the WHO global database on body mass index. SCN News 2004; 5-12.
68. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-61.
69. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-7.
70. Schunemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118: 656-64.
71. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313: 711-6.
72. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-28.
73. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-14.
74. Lam KB, Jordan RE, Jiang CQ, et al. Airflow obstruction and the metabolic syndrome: the Guangzhou Biobank Cohort Study. Eur Respir J 2010; 35: 317-23.
75. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82: 53-9.
76. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173: 79-83.
77. VanItallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA. Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 1990; 52: 953-9.
78. Schols AM, Soeters PB, Dingemans AMC, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147:1151-6.
79. Driver AG, Mc Alevy MT, Smith JL. Nutritional assessment of patients with chronic obstructive pulmonary disease and acute respiratory failure. Chest 1981; 82: 568-71.
80. Engelen MPKJ, Schols AMWJ, Baken WC, Wesseling GJ, Wouters EF. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in outpatients with COPD. Eur Respir J 1994; 7: 1793-7.
81. Lévy P, Pépin JL, Arnaud C, et al. Intermittent hypoxia and sleepdisordered breathing: current concepts and perspectives. Eur Respir J 2008; 32: 1082-95.
82. King DA, Cordova F, Scharf SM. Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5: 519-23.
83. Berry MJ, Rejeski J, Adair NE, et al. A randomized, controlled trial comparing long-term and short-term exercise in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2003; 23: 60-8.
84. Bendstrup KE, Ingemann-Jensen J, Holm S, et al. Outpatient rehabilitation improves activities of daily living, quality of life and exercise tolerance in chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2801-6.
85. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122: 823-32.
86. Cambach W, Wagenaar RC, Koelman TW, Ton van Keipema ARJ, Kemper HCG. The long-term effects of pulmonary rehabilitation in patients with asthma and chronic obstructive disease: a research synthesis. Arch Phys Med Rehabil 1999; 80: 103-11.
87. Foglio K, Bianchi L, Bruletti G, Battista L, Pagani M, Ambrosino N. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J 1999; 13: 125-32.
88. Troosters T, Gosselink R, Decramer M. Short-and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 2000; 109: 207-12.
89. de Godoy RF, Teixeira PJ, Júnior BB, Michelli M, de Godoy DV. Long-term repercussions of a pulmonary rehabilitation program on the indices of anxiety, depression, quality of life and physical performance in patients with COPD. J Bras Pneumol 2009; 35: 129-36.
90. Martin JE, Dubbert PM. Exercise applications and promotion in behavioral medicine: current status and future directions. J Consult Clin Psychol 1982; 30: 1004-17.
91. Epstein LH. Role of behavior theory in behavioral medicine. J Consult Clin Psychol 1992; 60: 493-504.
92. Criner GJ, Cordova FC, Furukawa S, et al. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 2018-27.
93. Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after pulmonary rehabilitation in chronic lung disease. Am J Respir Crit Care Med 2003; 167: 880-8.
94. Steinsbekk A, Lomundal BK. Three-year follow-up after a twoyear comprehensive pulmonary rehabilitation program. Chron Respir Dis 2009; 6: 5-11.
95. Donabedian A. The methods and findings of quality assessment and monitoring: an illustrated analysis. Ann Arbor, Mich: Health Administration Press 1985; p. 256.
96. Green L, Kreuter M, Deeds S, et al. Health education planning: a diagnostic approach. Palo Alto, Calif: Mayfield Publishing Co; 1980; p.306.
97. Jette AM. Outcomes research: shifting the dominant research paradigm in physical therapy. Phys Ther 1995; 75: 965-70.
98. Pashkow P, Ades PA, Emery CF, et al. Outcome measurement in cardiac and pulmonary rehabilitation by the AACVPR Outcomes Committee. J Cardiopulm Rehabil 1995; 15: 394-405.
99. Verrill D, Barton C, Beasley W, Lippard M. Quality of life measures and gender comparisons in North Carolina cardiac rehabilitation programs. J Cardiopulm Rehabil 2001; 18: 122-41.
100. Gulanick M, Gavic AM, Kramer V, Rey J. Outcomes in cardiac rehabilitation programs across Illinois. J Cardiopulm Rehabil 2002; 22: 329-33.
101. California Pulmonary Rehabilitation Collaborative Group. Effects of pulmonary rehabilitation on dyspnea, quality of life, and healthcare costs in California. J Cardiopulm Rehabil 2004; 24: 52-62.
102. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation. Joint ACCP/AACVPR evidenced-based clinical practice guidelines. Chest 2007; 131: 4S-42S.
103. Verrill D, Graham H, Vitcenda M, Peno-Green L, Kramer VV, Corbisiero T. Behavioral Outcomes in Cardiopulmonary Rehabilitation: An AACVPR Statement. J Cardiopulm Rehabil Prev 2009; 29: 193-203.
104. Riario-Sforza GG, Incorvaia C, Paterniti F, et al. Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: a number needed to treat study. Int J Chron Obstruct Pulmon Dis 2009; 4: 1-5.
105. Goldstein RS, Gort EH, Guyatt GH. Economic analysis of respiratory rehabilitation. Chest 1997; 112: 370-9.
106. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122: 823-32.
107. Cote CG, Thatcher R, Celli BR, et al. Mortality outcome of pulmonary rehabilitation followed by maintenance in patients with severe COPD. Am J Respir Crit Care Med 2003; 167s: A38.
108. Decramer M, Nici L, Nardini S, et al. Targeting the COPD exacerbation. Respir Med 2008; 102 (Suppl 1): S3-15.
109. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999; 318: 593-6.